Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
Follow UHS
Universal Health Services, Inc. (UHS) EV/Sales
As of 16 October 2026, Universal Health Services, Inc. (UHS) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from 0.7× (July 2026) to 2.0× (June 2015); the current reading is higher than 5% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.1× | 3.19% |
| FY2024 | 1.0× | (5.82%) |
| FY2023 | 1.1× | (3.05%) |
| FY2022 | 1.1× | (3.37%) |
| FY2021 | 1.2× | (5.71%) |
| FY2020 | 1.2× | (15.33%) |
| FY2019 | 1.5× | 6.80% |
| FY2018 | 1.4× | (5.02%) |
| FY2017 | 1.4× | (2.64%) |
| FY2016 | 1.5× | (11.67%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.7× | (14.18%) |
| Mar 2026 | 0.9× | (17.88%) |
| Dec 2025 | 1.1× | 3.59% |
| Sep 2025 | 1.0× | 4.99% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| THC Tenet Healthcare Corporation compare | 1.5× |
| DVA DaVita Inc. compare | 1.6× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| EHC Encompass Health Corporation compare | 2.4× |
| CHE Chemed Corporation compare | 2.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.7× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on UHS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement